Impact of the New EU HTA Regulation on Access to Innovative Medicines in Europe

Access to innovative medicines in Europe continues to be one of the major pending issues, especially considering the significant differences observed between countries. In recent years, the EU has developed a series of regulations that impact access. One of the most significant is the European Union Health Technology Assessment Regulation (EU HTA), aimed at addressing uneven access across the EU, among other goals.

Published on:
September 22, 2023
Chus Castillo

This new regulation will entail important changes for innovative companies. As part of #BIOSPAIN2023Interview initiative, Chus Castillo, Partner Consulting Iberia at Alira Health, spoke about the “Impact of the New EU HTA Regulation on Access to Innovative Medicines in Europe.”

Read Chus’ interview on AseBio’s website to get the latest updates on the HTA Regulation, related challenges, and its potential effect on access to innovative medicines.

Related news

News November 21, 2023
Alira Health to Present at the Piper Sandler 35th Annual Healthcare Conference
Alira Health announced that Gabriele Brambilla, Alira Health’s Chief Executive Officer and Co-Founder, and Piergiulio Lauriano, Chief Strategy Officer at Alira Health, will present(...)
Healthcare Technology Life Sciences
Events November 8, 2023
Spain Healthcare Innovation Summit
We will sponsor and speak at Spain Healthcare Innovation Summit, a premier event that brings together healthcare professionals from across Spain and beyond to discuss the latest developments(...)
Market Access Patient Centricity Spain
Blog November 7, 2023
Support of Real-World Evidence in the Price and Reimbursement Decision-Making​ Process for Rare Diseases in Spain
Explore the potential and challenges related to RWE in P&R decision-making for rare disease products in Spain, one of the most attractive markets in Europe because of universal healthcare.
Rare Disease Real-World Evidence (RWE) Spain
Multimedia November 2, 2023
How to Increase Patient Engagement in Your Clinical Trials
Join this webinar hosted by France Biotech to learn best practices and how to overcome challenges in engaging patients in your clinical trial.
Biotech France Patient Engagement
Blog October 16, 2023
Biotechs on the Rise
In the final article of our Biotech series, Joris Pezzini talks about the evolution of biotechs in the face of challenges and the drivers for future success.
Biotech Drug Development
Events October 15, 2023
CPHI Barcelona
Connect with us at CPHI in Barcelona and learn how we design tailor-made solutions to achieve your business goals at every step of the way.
Market Access Spain Transaction Advisory
Blog October 9, 2023
Inflation Reduction Act and Pharma – Navigating Uncertainty
What's the impact of the Inflation Reduction Act on small biotechs, mid-size companies and large pharma players, and how can they prepare?
Biotech Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.